Day: September 5, 2025

STUDY: Gencor’s Levagen®+ Demonstrates Significant Microbiome Activity

Gencor has published a new human clinical trial in Biomedicines showing that its palmitoylethanolamide (PEA) ingredient, Levagen®+, supports a balanced inflammatory response, healthy triglyceride levels, and functional changes in gut microbiome activity. The findings highlight Levagen®+ as a safe, bioavailable, and scientifically backed ingredient for metabolic health, immunity, and weight management.